New findings show natural hazards such as SCS and wildfire are reshaping global loss patterns and intensifying need for both…
Sales Highlights (unaudited): Global H1 sales AUD$4.2 million up 5% on prior comparative period (pcp)Q2 sales AUD$2.2 million up 11%…
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and…
January 16, 2026 17:05 ET | Source: Annexon Biosciences BRISBANE, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq:…
CHARLOTTE, N.C., Jan. 14, 2026 /PRNewswire/ -- Bank of America reported its fourth quarter 2025 financial results today. The news…
APAC Region Reported Double-Digit Year-over-Year Revenue IncreaseMILPITAS, Calif., Jan. 12, 2026 /PRNewswire/ -- Electronic System Design (ESD) industry revenue increased…
Washington, DC, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Washington Business Journals reports that Brian Ferdinand has initiated a protective federal filing under…
January 02, 2026 16:05 ET | Source: Terns Pharmaceuticals, Inc. FOSTER CITY, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Terns…
IRVINE, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical…
Growth Supported by Leading-edge Logic, Memory and Advanced Packaging Applications from 2025 through 2027TOKYO, Dec. 16, 2025 /PRNewswire/ -- Global…